Acquisition of Primaquine 15 mg Comp AUE DG 1315
About This Opportunity
TranslatedThis tender pertains to the acquisition of Primaquine 15 mg tablets, identified by the reference AUE DG 1315. Primaquine is an antimalarial medication used primarily for the treatment and prevention of malaria. The procurement is likely aimed at ensuring the availability of this essential drug for public health initiatives, particularly in regions where malaria is endemic. Key requirements for bidders may include compliance with pharmaceutical regulations, quality assurance standards, and the ability to deliver the product within specified timelines. Additionally, suppliers may need to demonstrate their capacity to meet the demand for this medication, ensuring that it is accessible to healthcare facilities. The tender is expected to attract pharmaceutical companies with experience in supplying antimalarial drugs to government health programs. It is crucial for interested parties to review the tender documents thoroughly to understand the specific terms and conditions, including submission deadlines and evaluation criteria. This procurement initiative underscores the commitment to combating malaria and improving health outcomes in affected populations.
This is a supplies contract in the health and medical services, information and communication technology and trade and industry sectors, with a focus on Pharmaceuticals, Infectious Diseases and Manufacturing. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 79.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: PortugueseThe tender titled "Aquisição de Primaquina 15 mg Comp AUE DG 1315" pertains to the procurement of Primaquine, a medication primarily used in the treatment of malaria. This tender is issued within the context of public health initiatives in Portugal, and it is likely aimed at ensuring the availability of essential pharmaceuticals for healthcare providers.
As part of the procurement process, the contracting authority is expected to seek qualified suppliers capable of providing Primaquine in a dosage of 15 mg, packaged appropriately for distribution and use. Suppliers must demonstrate compliance with regulatory standards governing pharmaceutical products in Portugal, including adherence to Good Manufacturing Practices (GMP) and relevant health and safety regulations.
Typical requirements for this type of tender may include the submission of documentation proving the supplier's capability to deliver the specified medication, including quality assurance certificates and product specifications. Additionally, suppliers may be required to provide evidence of previous experience in pharmaceutical supply, particularly in relation to anti-malarial drugs.
This tender is indicative of Portugal's commitment to maintaining effective healthcare solutions and addressing public health challenges. Suppliers interested in participating in this tender should ensure they are registered with the appropriate governmental procurement platforms and are prepared to meet the deadlines and criteria outlined in the tender documents. The information is centralized through the BASE portal, which serves as a resource for public contracts across Portugal and its autonomous regions, ensuring transparency and accessibility for potential bidders.
Data provenance
This notice is sourced from base_gov_pt and was originally published on February 10, 2026. Last refreshed 8 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde do Alto Minho, EPE (ULSAM)
Unidade Local de Saúde do Alto Minho, EPE (ULSAM) has issued 512 procurement notices on BidsFactory, including 0 currently open and 462 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Governance & Public Administration. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde do Alto Minho, EPE (ULSAM) in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is Up to €79. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to DUXPHARMA. The award notice is archived on BidsFactory for transparency and market intelligence.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.